Hrt Financial LP Catalyst Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.19 - $21.35 $1.61 Million - $2.26 Million	105,743 New	105,743 $2.1 Million
Q4 2023 Feb 09, 2024	SELL	$11.78 - $17.29 $235,635 - $345,851	-20,003 Reduced 34.71%	37,623 $632,000
Q3 2023 Nov 13, 2023	BUY	$11.69 - $15.02 $488,022 - $627,039	41,747 Added 262.91%	57,626 $673,000
Q2 2023 Aug 11, 2023	SELL	$11.5 - $18.08 $2.37 Million - $3.73 Million	-206,299 Reduced 92.85%	15,879 $213,000
Q1 2023 May 12, 2023	BUY	$14.34 - $21.05 $2.7 Million - $3.96 Million	188,073 Added 551.45%	222,178 $3.68 Million
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $10,878 - $17,316	888 Added 2.67%	34,105 $634,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $1.09 Million - $2.4 Million	-154,902 Reduced 82.34%	33,217 $426,000
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $1.17 Million - $1.61 Million	188,119 New	188,119 $1.32 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $702,863 - $1.1 Million	-132,366 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $515,717 - $737,445	98,986 Added 296.54%	132,366 $896,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $161,893 - $201,615	33,380 New	33,380 $176,000
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $375,063 - $509,868	-108,714 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $322,880 - $416,374	108,714 New	108,714 $363,000
Q3 2020 Nov 13, 2020	SELL	$2.97 - $5.08 $148,167 - $253,431	-49,888 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $173,610 - $251,934	49,888 New	49,888 $230,000

345

98.4M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.